Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy AtriCure (ATRC) stocks in Canada
Learn how to easily invest in AtriCure stocks.
AtriCure is a medical instruments & supplies business based in the US. AtriCure stocks (ATRC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $81.5 – a decrease of 4.93% over the previous week. AtriCure employs 750 staff and has a trailing 12-month revenue of around $258.8 million.
How to buy shares in AtriCure
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ATRC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in AtriCure?
- Has coronavirus impacted AtriCure shares?
- AtriCure shares summary
- Compare share dealing platforms
- Is AtriCure stock a buy or sell?
- AtriCure performance over time
- Are AtriCure shares over-valued?
- AtriCure's financials
- How volatile are AtriCure shares?
- Does AtriCure pay a dividend?
- Other common questions
AtriCure stock price (NASDAQ:ATRC)Use our graph to track the performance of ATRC stocks over time.
AtriCure shares at a glance
|Latest market close||$63.63|
|52-week range||$55.77 - $89.18|
|50-day moving average||$71.56|
|200-day moving average||$73.81|
|Wall St. target price||$99.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.99|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy AtriCure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
AtriCure price performance over time
|1 week (2022-01-12)||-6.97%|
|1 month (2021-12-17)||-6.18%|
|3 months (2021-10-16)||N/A|
|6 months (2021-07-20)||-19.87%|
|1 year (2021-01-20)||11.24%|
|2 years (2020-01-17)||66.35%|
|3 years (2019-01-18)||100.54%|
|5 years (2017-01-20)||321.39%|
Is AtriCure under- or over-valued?
Valuing AtriCure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AtriCure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AtriCure's P/E ratio
AtriCure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 66x. In other words, AtriCure shares trade at around 66x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Revenue TTM||$258.8 million|
|Gross profit TTM||$149.3 million|
|Return on assets TTM||-3.94%|
|Return on equity TTM||10.02%|
|Market capitalisation||$3 billion|
TTM: trailing 12 months
AtriCure share dividends
We're not expecting AtriCure to pay a dividend over the next 12 months.
AtriCure share price volatility
Over the last 12 months, AtriCure's shares have ranged in value from as little as $55.77 up to $89.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AtriCure's is 1.1526. This would suggest that AtriCure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. It offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. The company also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used to treat symptomatic persistent and long-standing persistent atrial fibrillation patients; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, it sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; COBRA Fusion Surgical Ablation System; Fusion Magnetic Retriever System; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company markets and sells its products through independent distributors and direct sales personnel. AtriCure, Inc.
Stocks similar to AtriCure
AtriCure in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
AtriCure Inc. (ATRC) Fell Out Of Favor With Hedge Funds?
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?
Frequently asked questions
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.